Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 9Neoplasms 6Prostatic Neoplasms 5Colorectal Neoplasms 4Uterine Cervical Neoplasms 3Lung Neoplasms 3Thyroid Neoplasms 2Lymphoma 2Communication 2Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Patient Preference 1Papillomavirus Infections 1Papillary Thyroid Microcarcinoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Motor Activity 1Melanoma 1Leukemia 1Hematologic Neoplasms 1Health Behavior 1HIV Infections 1Coitus 1Carcinoma, Transitional Cell 1Cancer Prevention 1

Interventions

Methadone 2oxycodone naloxone combination 1Tapentadol 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Pharmacogenomic Testing 1Oxycodone 1Morphine 1Interviews as Topic 1Hydromorphone 1Focus Groups 1Fentanyl 1Diagnostic Tests, Routine 1Buprenorphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cancer Pain × Focus Groups × Clear all
NCT01230515 2012-09-10

Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol

Vanderbilt-Ingram Cancer Center

Completed
65 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡